Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials

Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants

(2016) Robert M. Berman et al.   CNS SPECTRUMS

Role of Lithium Augmentation in the Management of Major Depressive Disorder

(2014) Michael Bauer et al.   CNS DRUGS

Ketamine administration in depressive disorders: a systematic review and meta-analysis

(2014) Guillaume Fond et al.   PSYCHOPHARMACOLOGY

The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives

(2014) Andre F. Carvalho et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

(2013) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: A randomized, double-blind, placebo-controlled study (ADMIRE study)

(2013) Kunitoshi Kamijima et al.   JOURNAL OF AFFECTIVE DISORDERS

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

(2013) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: A European perspective

(2013) Pauline Turner et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature

(2013) Bradley M. Wright et al.   PHARMACOTHERAPY

Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes

(2013) Glen I. Spielmans et al.   PLOS MEDICINE

Vilazodone: A novel antidepressant

(2012) E. Choi et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Combination of Antidepressants in the Treatment of Major Depressive Disorder

(2012) Fábio Lopes Rocha et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Predictors of Response to Ziprasidone: Results from a 6-Week Randomized Double-Blind, Placebo-Controlled Trial for Acute Depressive Mixed State

(2012) C.-U. Pae et al.   PHARMACOPSYCHIATRY

A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State

(2012) Ashwin Patkar et al.   PLoS One

Therapeutic options in treatment-resistant depression

(2011) Eduard Vieta et al.   ANNALS OF MEDICINE

Adjunctive Low-Dose Aripiprazole With Standard-Dose Sertraline in Treating Fresh Major Depressive Disorder

(2011) Chien-Ho Lin et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Escitalopram

(2010) Karly P. Garnock-Jones et al.   CNS DRUGS

Second-generation antipsychotics in major depressive disorder: update and clinical perspective

(2010) Jun Chen et al.   CURRENT OPINION IN PSYCHIATRY

Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin–norepinephrine reuptake inhibitor

(2010) Alice I Nichols et al.   Expert Opinion on Drug Metabolism & Toxicology

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

(2010) Nizar El-Khalili et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Antidepressant Drug Effects and Depression Severity

(2010) Jay C. Fournier et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials

(2009) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder

(2009) Amir Garakani et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

(2009) Michael Bauer et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY